Antinociceptive effects of the endogenous cannabinoid peptide agonist VD-hemopressin(β) in mice.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Brain Research Bulletin

• Publication date

  2018-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.brainresbull.2018.02.003PMID 29425797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage

  2017cited by this paper
• Pharmacological characterization of rat VD-hemopressin(α), an α-hemoglobin-derived peptide exhibiting cannabinoid agonist-like effects in mice.

  2017cited by this paper
• Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats

  2017cited by this paper
• Anorexigenic effects induced by RVD-hemopressin(α) administration

  2017cited by this paper
• Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools.

  2016cited by this paper
• Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice

  2016cited by this paper
• BN‐9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance‐forming antinociception in mice

  2016cited by this paper
• Investigation of receptor binding and functional characteristics of hemopressin(1-7).

  2016cited by this paper
• The endocannabinoid system in renal cells: regulation of Na+ transport by CB1 receptors through distinct cell signalling pathways

  2015cited by this paper
• Further Characterization of Hemopressin Peptide Fragments in the Opioid and Cannabinoid Systems

  2015cited by this paper
• Anxiogenic-like effects induced by hemopressin in rats.

  2015cited by this paper
• The hypotensive effect of intrathecally injected (m)VD-hemopressin(α) in urethane-anesthetized rats.

  2014cited by this paper
• Antinociceptive Effects of Central Administration of the Endogenous Cannabinoid Receptor Type 1 Agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-Terminally Extended Hemopressin Peptide

  2014cited by this paper
• Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice.

  2014cited by this paper
• Modulation of the cannabinoid receptors by hemopressin peptides.

  2013cited by this paper
• Effects of endokinin A/B and endokinin C/D on the antinociception properties of hemopressin in mice.

  2012cited by this paper
• The Effects of Peptide and Lipid Endocannabinoids on Arthritic Pain at the Spinal Level

  2012cited by this paper
• Effects of neuropeptide FF system on CB₁ and CB₂ receptors mediated antinociception in mice.

  2012cited by this paper
• Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors*

  2012cited by this paper
• Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities

  2012cited by this paper
• Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception.

  2011cited by this paper
• THEMED ISSUE: CANNABINOIDS RESEARCH PAPER Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain

  2010cited by this paper
• Novel endogenous peptide agonists of cannabinoid receptors

  2009cited by this paper
• Potential anxiolytic‐ and antidepressant‐like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents

  2009cited by this paper
• Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.

  2008cited by this paper
• Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.

  2008cited by this paper
• Hemopressin is an inverse agonist of CB1 cannabinoid receptors

  2007cited by this paper
• The Additive Antinociceptive Interaction Between WIN 55,212-2, a Cannabinoid Agonist, and Ketorolac

  2006cited by this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cited by this paper
• Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats

  2004cited by this paper
• CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

  2004cited by this paper
• Cannabinoids in pain and inflammation

  2004cited by this paper
• Topical cannabinoid antinociception: synergy with spinal sites

  2003cited by this paper
• A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain

  2003cited by this paper
• Antagonism between the Anti-Inflammatory Activity of the Cannabinoid WIN 55212-2 and SR 141716A

  2003cited by this paper
• The cannabinoid receptors.

  2002cited by this paper
• Inhibition of Improgan Antinociception by the Cannabinoid (CB)1 AntagonistN-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): Lack of Obligatory Role for Endocannabinoids Acting at CB1 Receptors

  2002cited by this paper
• Cannabinoid receptors and pain.

  2001cited by this paper
• The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

  2001cited by this paper
• The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

  2001cited by this paper
• Cannabinoids modulate pain by multiple mechanisms of action

  2000cited by this paper
• Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.

  1998cited by this paper
• Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.

  1998cited by this paper
• Pharmacology of cannabinoid CB1 and CB2 receptors.

  1997cited by this paper
• Intrathecal morphine in mice: a new technique.

  1980cited by this paper

• Modulation of chemotherapy-induced peripheral neuropathy by JZL195 through glia and the endocannabinoid system.

  2024cites this paper
• The Endogenous Cannabinoid and the Nitricoxidergic Systems Differently Influence Heat and Cold Stress-Induced Analgesia

  2021cites this paper
• Hemoglobin-derived peptides and mood regulation.

  2020cites this paper
• The role of the cannabinoid system in opioid analgesia and tolerance.

  2020cites this paper
• Intracellular Peptides in Cell Biology and Pharmacology

  2019cites this paper
• Recent progress in non-opioid analgesic peptides.

  2018cites this paper